Oculis Holding AG
OCS
$14.75
$0.382.64%
Weiss Ratings | OCS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Very Weak | |||
Risk Index | Weak | |||
Risk Grade | D | |||
Reward Grade | E | |||
Rating Factors | OCS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | -- | |||
Growth Index | Weak | |||
Efficiency Index | Very Weak | |||
Solvency Index | Excellent | |||
Total Return Index | Good | |||
Volatility Index | Fair | |||
Beta / Standard Deviation | OCS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 0.80 | |||
Price History | OCS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | -23.10% | |||
30-Day Total Return | -28.98% | |||
60-Day Total Return | -30.26% | |||
90-Day Total Return | -0.27% | |||
Year to Date Total Return | -12.88% | |||
1-Year Total Return | 37.08% | |||
2-Year Total Return | 82.32% | |||
3-Year Total Return | 50.82% | |||
5-Year Total Return | -- | |||
52-Week High % Change | -37.74% | |||
52-Week Low % Change | 35.44% | |||
Price | OCS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $23.08 | |||
52-Week Low Price | $10.61 | |||
52-Week Low Price (Date) | Apr 08, 2024 | |||
52-Week High Price (Date) | Jan 13, 2025 | |||
Valuation | OCS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 760.80M | |||
Enterprise Value | 653.23M | |||
Price/Earnings (TTM) | -- | |||
Earnings Per Share (TTM) | -2.39 | |||
Earnings Per Share Growth | -54.12% | |||
Price/Earnings To Growth | -- | |||
Price/Sales (TTM) | 793.92 | |||
Price/Book (Q) | 7.75 | |||
Enterprise Value/Revenue (TTM) | 839.73 | |||
Price | $14.75 | |||
Enterprise Value/EBITDA (TTM) | -7.91 | |||
Enterprise Value/EBIT | -7.87 | |||
Market Cap Category | Small Cap | |||
Dividends and Shares | OCS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 42.77M | |||
Dividend Yield | -- | |||
Div. Per Share (Most Recent) | -- | |||
Dividend Per Share (TTM) | -- | |||
Payout Ratio (TTM) | -- | |||
Dividend Per Share (Most Recent) | -- | |||
Company Info | OCS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 41-41-711-3960 | |||
Address | -- | |||
Website | oculis.com | |||
Country | Switzerland | |||
Year Founded | 2017 | |||
Profitability | OCS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | -10,671.35% | |||
Profit Margin | -12,523.92% | |||
Management Effectiveness | OCS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | -38.63% | |||
Return on Equity | -- | |||
Income Statement | OCS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | 777.90K | |||
Total Revenue (TTM) | 777.90K | |||
Revenue Per Share | $0.02 | |||
Gross Profit (TTM) | -58.27M | |||
EBITDA (TTM) | -82.55M | |||
EBIT (TTM) | -83.01M | |||
Net Income (TTM) | -97.42M | |||
Net Income Avl. to Common (TTM) | -97.42M | |||
Total Revenue Growth (Q YOY) | -98.37% | |||
Earnings Growth (Q YOY) | -131.16% | |||
EPS Diluted (TTM) | -2.39 | |||
EPS Diluted Growth (Q YOY) | -98.67% | |||
Balance Sheet | OCS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 108.88M | |||
Cash Per Share (Q) | $2.55 | |||
Total Current Assets (Q) | 115.76M | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | 80.98M | |||
Current Ratio (Q) | 2.371 | |||
Book Value Per Share (Q) | $1.85 | |||
Total Assets (Q) | 132.81M | |||
Total Current Liabilities (Q) | 48.81M | |||
Total Debt (Q) | 1.30M | |||
Total Liabilities (Q) | 51.83M | |||
Total Common Equity (Q) | 80.98M | |||
Cash Flow | OCS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | -19.32M | |||
Cash from Financing (TTM) | 59.81M | |||
Net Change in Cash (TTM) | -12.95M | |||
Levered Free Cash Flow (TTM) | -9.06M | |||
Cash from Operations (TTM) | -53.89M | |||